Since intramyocyte LD accumulation precedes onset of cardiac dysfunctions in individuals with obesity or diabetes5,39, our in vivo LIPTER transgene data strongly suggest that targeted LIPTER delivery into heart muscle might be an effective strategy to prevent cardiac dysfunction and heart failure in metabolic syndromes. Here, LINC00881 is linked to metabolic syndrome.